Brain-storming Solutions for Neurological Disorders

Brain-storming Solutions for Neurological Disorders

From Science Queeries by JOY 94.9 - Rainbow Community Podcasts for our LGBTI, LGBTIQA+, LGBTQIA+, LGBT, LGBTQ, LGB, Gay, Lesbian, Trans, Intersex, Queer Communities

June 2, 2026 · 42 min

About this episode

This episode discusses the genetic basis of neurological disorders and potential treatments with Dr. Matt Coleman.

The brain is complex – billions of neurons, trillions of connections, and countless ways things can go wrong. Brain malformations and severe epilepsies can derail development, disrupt learning, and change lives forever. And sometimes, the cause remains a mystery. Until now. Genetic testing is unlocking answers. Translational genetics is rewiring how we approach treatment. And understanding the genetic code behind these conditions could be game-changing. This week, we’re brain-storming solutions with Dr Matt Coleman who spent years at Murdoch Children’s Research Institute investigating the genetic basis of neurological disorders. He’s passionate about using genetic knowledge to develop treatments that can transform lives, which he now does as Medical Science Liaison at UCB Pharmaceuticals. Because when we decode the brain’s code, we can rewrite the story for patients and their families. Originally aired 26th May, 2026. The post Brain-storming Solutions for Neurological Disorders appeared first on Science Queeries .

People in this episode

Guest: Dr Matt Coleman

Topics covered

  • neurological disorders
  • genetic testing
  • treatment development
  • brain malformations
  • epilepsy
  • translational genetics

Keywords

  • neurological disorders
  • genetic testing
  • brain malformations
  • epilepsy
  • treatment
  • translational genetics
  • medical science

Mentioned in this episode

Organizations: Murdoch Children’s Research Institute, UCB Pharmaceuticals

More episodes of Science Queeries

Explore listener stats, chart rankings, contacts and more on the Science Queeries podcast page.